Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Teresa Pombo"'
Autor:
Dana Narvaez, Jorge Nadal, Adrian Nervo, María Victoria Costanzo, Claudio Paletta, Fernando E. Petracci, Sergio Rivero, Alexis Ostinelli, Berenice Freile, Diego Enrico, Maria Teresa Pombo, Mora Amat, Edgar Danilo Aguirre, Matias Chacon, Federico Waisberg
Publikováno v:
Cancers, Vol 16, Iss 2, p 396 (2024)
This narrative review aims to clarify the role of tertiary lymphoid structures in breast cancer. We examine their development, composition, and prognostic value, and current ways of recognizing them. A comprehensive literature review was performed us
Externí odkaz:
https://doaj.org/article/6464ee3c2a254b60a5795056c5bb1b4f
Autor:
Federico Esteso, Natalia Soledad Tissera, Juan Manuel O'Connor, Romina Luca, Eduardo Huertas, Fernando Sánchez Loria, Ivana Pedraza, Alejandro Pairola, Fernando Brancato, Lisandro Paganini, Mariana Kucharczyk, Mora Amat, Maria Teresa Pombo, Mariana Galli, Luisina Bruno, Luis Caro, Andrés Rodriguez, Diego Enrico, Federico Waisberg, Matías Chacón
Publikováno v:
World Journal of Clinical Oncology. 13:423-428
Given the increasing complexity of cancer care, multidisciplinary tumor boards have become essential in daily clinical oncology practice. The Project Extension for Community Healthcare Outcomes (ECHO) initiative developed an innovative telementoring
Autor:
Laura Sabina Lapuchesky, Marcos Bortz, Federico Waisberg, Diego Hernán Enrico, Luisina Ines Bruno, Cristian Alexis Ostinelli, Sergio Gabriel Rivero, Andres Rodriguez, Martin Zarba, Martin Loza, Verónica Yamila Fabiano, Mora Amat, Maria Teresa Pombo, Maria Laura Noro, Federico Andrés Coló, Reinaldo D. Chacon, Matias Rodrigo Chacon, Jorge Carlos Nadal, Adrian Nervo, Maria Victoria Costanzo
Publikováno v:
Journal of Clinical Oncology. 40:1056-1056
1056 Background: HER2-low expression, defined as HER2 immunohistochemistry (IHC) score of 1+ or 2+ with negative in situ hybridization assay (FISH), accounts for 50% of breast cancers. There is limited and conflicting evidence regarding the efficacy
Autor:
Carolina Ponce, Verónica Fabiano, Constanza Pérez de la Puente, Maria Victoria Costanzo, Mora Amat, Federico Coló, Manglio Rizzo, Chacon Reinaldo, Pablo Mandó, Carlos Martin Loza, Jorge Nadal, Maria Teresa Pombo, Adrian Nervo, M Maino, Jose Loza
Publikováno v:
Journal of Breast Cancer
Purpose Several studies have shown that estrogen receptor (ER) and progesterone receptor (PR) expression and human epidermal growth factor receptor 2 (HER2) expression may vary during tumoral progression. We aimed to describe and compare ER, PR, and